News

Philippines Medical Tourism: Accredited Hospitals, Competitive Costs & Rising Medical Device Demand – October/November 2026

Philippines Medical Tourism: Accredited Hospitals, Competitive Costs & Rising Medical Device Demand – October/November 2026

  • 2026-11-19 04:42:27

Ranked Southeast Asia's 3rd-largest medical tourism destination, the Philippines offers 6 JCI-accredited hospitals and treatment costs 40-80% lower than in Western countries. Cosmetic surgery, cardiology, and oncology lead patient demand, while fertility treatment grows fastest. With medical tourism projected to reach US$5B by 2034 and device imports up 15% in 2025, diagnostic imaging, cardiology, and dialysis devices show strong potential.

More
Indonesia: Guidelines for Marketing Authorization of Software-Based Medical Devices – October/November 2026

Indonesia: Guidelines for Marketing Authorization of Software-Based Medical Devices – October/November 2026

  • 2026-11-19 02:55:13

The Ministry of Health (MoH) of Indonesia has issued Minister of Health Decree No. HK.01.07/MENKES/951/2026 concerning Guidelines for Marketing Authorization of Software-Based Medical Devices, dated 7 September 2026. The decree establishes technical requirements and procedures for obtaining marketing authorization (Izin Edar) for software-based medical devices distributed in Indonesia. The new guidelines cover Software as a Medical Device (SaMD), Software in a Medical Device (SiMD), and medical devices incorporating Artificial Intelligence (AI) applications. They aim to ensure the safety, performance, and quality of software-based medical devices while addressing emerging regulatory considerations, including software lifecycle management, cybersecurity, clinical validation, and personal data protection.

More
Singapore: HSA Medical Device Updates – Registration Guidance, Premarket Checklist and Concurrent Change Notifications – October/November 2026

Singapore: HSA Medical Device Updates – Registration Guidance, Premarket Checklist and Concurrent Change Notifications – October/November 2026

  • 2026-11-19 02:22:44

Singapore's Health Sciences Authority (HSA) announced several important medical device regulatory updates in September 2026, covering product registration guidance, premarket submission requirements and concurrent Change Notification (CN) applications.
These developments include revised product registration guidance documents, the introduction of a Premarket Submission Checklist and further clarification of concurrent CN procedures. Together, the updates aim to support more consistent regulatory submissions and improve the efficiency of medical device registration and post-registration change management in Singapore.

More
QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

  • 2026-10-27 06:15:00

Qualtech's webinar on September 17, 2026 reviewed key regulatory developments for medical devices in Japan and South Korea. The Japan session covered how existing biocompatibility reports can support PMDA submissions, including JIS T 0993-1:2020 requirements, material documentation, GLP compliance and the acceptance of overseas test data. The South Korea session outlined the Digital Medical Products Act framework, covering device status determination, classification, regulatory pathways, K-GMP and post-market obligations.

More
SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

  • 2026-10-27 05:15:40

Singapore's Health Sciences Authority (HSA) has introduced the submission window for the inaugural year of the Registration Support Initiative for unregistered medical device previously have been accessed through Special Access Routes (SAR) to 31 December 2026. This provides medical and dental practitioners and other stakeholders with additional time to prepare submissions, engage relevant parties and obtain the necessary endorsements. From 2027 onwards, the Initiative will follow a standard annual submission cycle from 1 October to 31 December.

More
SINGAPORE: HSA PUBLISHES FINALISED GL-10 R1 BEST PRACTICES GUIDE ON MEDICAL DEVICE CYBERSECURITY – September/October 2026

SINGAPORE: HSA PUBLISHES FINALISED GL-10 R1 BEST PRACTICES GUIDE ON MEDICAL DEVICE CYBERSECURITY – September/October 2026

  • 2026-10-27 04:39:09

Singapore's Health Sciences Authority (HSA) has published the finalised GL-10 R1 Best Practices Guide on Medical Device Cybersecurity following a public consultation conducted from 10 March to 13 May 2025. The guide provides best practice recommendations and considerations for managing cybersecurity risks associated with connected medical devices throughout the Total Product Life Cycle (TPLC). HSA also published a summary of responses to stakeholder feedback received during the consultation.

More
Philippines: PFDA Updates Draft Guidelines on Medical Device Labeling Requirements – September/October 2026

Philippines: PFDA Updates Draft Guidelines on Medical Device Labeling Requirements – September/October 2026

  • 2026-10-27 04:18:58

The Food and Drug Administration of the Philippines (PFDA) has released a draft FDA Circular proposing detailed guidelines for medical device labeling in the Philippines. The draft provides more specific requirements on labeling content and placement, device-specific labeling, electronic labeling, and regulatory actions for non-compliance. It also proposes a two-year transition period for medical devices already registered and available in the Philippine market. While the Circular remains in draft form, it reflects PFDA's direction toward more detailed and specific medical device labeling requirements.

More
Philippines: PFDA Circulates Revised Draft Regulatory Guidelines for Medical Device Software (MDSW) – September/October 2026

Philippines: PFDA Circulates Revised Draft Regulatory Guidelines for Medical Device Software (MDSW) – September/October 2026

  • 2026-10-26 09:52:44

The Food and Drug Administration of the Philippines (PFDA) has circulated a revised draft Circular proposing updated regulatory guidelines for Medical Device Software (MDSW), including AI-enabled MDSW. The draft outlines software qualification criteria, risk-based classification, product authorization pathways, and technical documentation requirements for initial and renewal applications. It also introduces AI-specific requirements covering clinical validation, cybersecurity, risk management, and post-market monitoring. The proposed guidelines aim to strengthen the safety and performance of MDSW throughout its lifecycle. The Circular remains in draft form and is not yet effective.

More
South Korea: Recent MFDS Regulatory Updates – Medical Device Adverse Event Reporting and KGMP – September/October 2026

South Korea: Recent MFDS Regulatory Updates – Medical Device Adverse Event Reporting and KGMP – September/October 2026

  • 2026-10-26 09:33:44

The Ministry of Food and Drug Safety (MFDS) of South Korea has recently revised regulations concerning medical device adverse event reporting and Korean Good Manufacturing Practice (KGMP) and introduced a new regulation governing the designation and management of organizations involved in medical device quality management.
These regulatory updates aim to clarify adverse event reporting requirements and timelines, while improving regulatory clarity by separating KGMP conformity assessment requirements from provisions governing assessment bodies and training organizations.
This newsletter provides an overview of three regulatory updates that took effect on July 1 and September 22, 2026.

More